Clinical Trial Update: YUKON-drug-eluting Stent Below The Knee - Randomised Double-blind Study [Phase 4]

View source ↗

Summary

A Phase 4 randomized double-blind trial evaluating the YUKON drug-eluting stent for arterial occlusive disease has completed. The sponsor is Herz-Zentrums Bad K…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• YUKON Drug Eluting Stent

Snippet

Sponsor: Herz-Zentrums Bad Krozingen | Conditions: Arterial Occlusive Diseases | Phase 4 | Status: COMPLETED